Verano Holdings reported revenue up 19% to $879m in 2022 from $738m in 2021 and said it will continue to strengthen its business portfolio by focusing on targeted expansion and new product launches ...
US cannabis company Columbia Care recorded a positive performance in 2022, despite macroeconomic headwinds that impacted consumers as well as wholesale market pricing ...
New markets and new products helped US cannabis operator Ascend Wellness Holdings (AWH) to its best year yet in 2022, the company said when presenting its full year results ...
Republicans are favoured over Democrats to take control of both chambers of US Congress in the midterm elections, but there are supporters and naysayers among both major parties when it comes to cannabis legalisation ...
The Republican-influenced National Conference of State Legislatures (NCSL) has explicitly called on the US federal government to support cannabis legalisation measures ...
Cannabis will be available for recreational use in Rhode Island from 1st December after governor Dan McKee signed the Rhode Island Cannabis Act into law, making the state the 19th in the US to legalise...
Governors and lawmakers from six US states have met at a regional cannabis and vaping summit in an attempt to establish more collective standardised regulations and legislative approaches ...
Moves are under way in a number of US states to take executive action against various vapour products. Meanwhile, a Kentucky CBD firm is suing for $44m an Oregon company it says sold it “nearly...
CBD is being brought reluctantly into the recent growing concern surrounding an unexplained lung condition affecting more than 120 people across the US ...
CBD-Intel’s regular round-up of regulatory news features items from the US, Mexico, Germany, Italy, Spain, Thailand, Trinidad and Tobago, and the self-governing UK dependency of Jersey ...
The first in a new weekly round-up from around the US brings you news from Colorado, Florida, Indiana, Maine, New Jersey, New York, North Dakota, and Tennessee ...
Start your FREE trial
Get 7 days of access to industry updates through our news analysis and regulatory alerts